Owner Centelion S.A.S. Aventis Pharmaceuticals Inc

Inventors Soubrier, Fabienne

Agent Watermark

Pub. Number AU-A-2009201405

Parent 2003287078

Filing date 9 April 2009

Wipo publication date 7 May 2009

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 15/00 (2006.01) Mutation or genetic engineering

C12N 15/64 (2006.01) Mutation or genetic engineering - General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host

C12N 15/69 (2006.01) Mutation or genetic engineering

C12N 15/70 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for E. coli

C12N 15/74 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12R 1/01 (2006.01)